Goat serum-derived polyclonal antibodies

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameGoat serum-derived polyclonal antibodies
Drug Alias NameAimsproCerembenCaprivaxHICS
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunomodulatorsCorticotropin-releasing hormone stimulants
TargetsCorticotropin-releasing hormone
Therapy Area/IndicationsScleroderma, SystemicMultiple Sclerosis, Chronic Progressive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDaval International Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaval International Ltd
Active IndicationsN/A
Inactive IndicationsScleroderma, SystemicMultiple Sclerosis, Chronic Progressive

Other Information

ATC CodeN/A
Related LinksN/A